ArticleOpen heart2024

Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trial.

Aleksi J Leikas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.